Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yiqi Hewei Capsule (益气和胃胶囊) is a proprietary Traditional Chinese Medicine (TCM) developed and manufactured by Hefei Everlife Pharmaceutical. It is primarily indicated for the treatment of chronic atrophic gastritis, specifically for patients presenting with patterns of Qi deficiency and stomach heat in TCM diagnosis. The formulation is designed to tonify Qi, harmonize the stomach, and clear heat, thereby relieving clinical symptoms such as epigastric pain, abdominal distension, dry mouth, and a bitter taste. As a multi-component herbal formulation, it functions through a holistic approach to restore gastric mucosal health and balance digestive function. It is approved in China and administered as an oral capsule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yiqi hewei capsule.